Navigating an Increasingly Complex Framework to Improve Patient Outcomes With ICI-Based Therapy

Review multidisciplinary best practices for safely and effectively incorporating immunotherapies into the management of diverse cancers with downloadable slides a Webcast expert commentaries and microlearning opportunities. Then get individualized recommendations adapted from NCCN Guidelines® for managing immune-related adverse events with a decision support tool.

Share

Program Content

No activities added yet

Activities

Common irAEs: Slides
A Practical Guide to Managing Common Immune-Related Adverse Events: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 23, 2021

Expires: March 22, 2022

Less Common irAEs: Slides
A Practical Guide to Managing Less Common Immune-Related Adverse Events: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 23, 2021

Expires: March 22, 2022

ICI Essentials
Immune Checkpoint Inhibitor Essentials: Key Principles, Indications, and Clinical Biomarkers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 16, 2021

Expires: April 15, 2022

irAE Management
Multidisciplinary Management of Immune-Related Adverse Events
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 16, 2021

Expires: April 15, 2022

ICIs & COVID-19 Vaccines
Emerging Guidance on COVID-19 Vaccination in Patients Receiving Immune Checkpoint Inhibitors: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 17, 2021

Expires: June 16, 2022

Starting ICI: Slides
What to Expect When Your Patient Is Starting Immune Checkpoint Inhibitor–Based Therapy: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 23, 2021

Expires: March 22, 2022

<i>EP</i>: ICI-Based Therapy
ExpressPoints: Navigating an Increasingly Complex Framework to Improve Patient Outcomes With ICI-Based Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 27, 2021

Expires: April 26, 2022

No activities added yet

Activities

ICI Max Efficacy Min Risk
Maximizing Efficacy, Minimizing Risk: New Biomarkers and Ongoing Challenges With ICIs
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 30, 2020

Expires: November 29, 2021

Activities

NCCN<sup>®</sup> Managing irAEs Tool
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Managing Immune Checkpoint Inhibitor Related Toxicities: An Interactive Decision Support Tool
Tool
Congratulations: You achieved a completion on 04/09/2022

Faculty

cover img faculity

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP

Associate Professor
Coordinator of Oncology Concentration

Yale University School of Nursing
Oncology Nurse Practitioner
Medical Oncology
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut

cover img faculity

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

cover img faculity

Sandip P. Patel, MD

Professor, Medical Oncology, UC San Diego
Leader, Experimental Therapeutics
Deputy Director, Sanford Stem Cell Clinical Center
Co-Leader, Solid Tumor Therapeutics Program
Medical Director, Clinical Research Informatics
La Jolla, California

cover img faculity

Jeffrey S. Weber, MD, PhD

Senior Member and Director
Comprehensive Melanoma Research Center
H. Lee Moffitt Cancer Center
Tampa, Florida

cover img faculity

Matthew Zibelman, MD

Assistant Professor
Hematology Oncology
Attending Physician
Genitourinary Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Merck Sharp & Dohme Corp.